Published in Int J Geriatr Psychiatry on June 01, 2008
Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression. Int J Geriatr Psychiatry (2010) 0.84
Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. Int J Alzheimers Dis (2011) 0.81
Behavioral and psychological symptoms in Alzheimer's disease. Biomed Res Int (2014) 0.79
A depressive endophenotype of mild cognitive impairment and Alzheimer's disease. PLoS One (2013) 0.77
APOE ϵ4, rated life experiences, and affect among centenarians. Aging Ment Health (2013) 0.75
The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. Depress Anxiety (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Cerebral blood flow in dementia. Arch Neurol (1975) 9.24
Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ (2001) 6.32
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol (2003) 2.56
Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol (1994) 2.24
Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke (2004) 1.93
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci (1997) 1.73
Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry (1989) 1.69
Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry (2000) 1.64
Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry (2002) 1.57
Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry (1996) 1.56
The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase (2005) 1.49
The incremental direct costs associated with behavioral symptoms in AD. Neurology (2002) 1.48
Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc (1999) 1.47
APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology (1999) 1.43
Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry (2002) 1.39
A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry (1997) 1.39
Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem (2000) 1.36
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology (2002) 1.25
Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta (1999) 1.22
Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci (1997) 1.21
APOE genotype influences acquisition and recall following traumatic brain injury. Neurology (2002) 1.21
The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry (1999) 1.19
Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol (1996) 1.00
Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology (2001) 0.95
Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study. Neurology (2001) 0.93
Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry (1999) 0.92
Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men. Dement Geriatr Cogn Disord (2002) 0.91
A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology (1996) 0.91
Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry (1999) 0.91
Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol Psychiatry (1999) 0.89
Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2000) 0.88
Association of the APOE epsilon 4 allele with clinical subtypes of late life depression. Biol Psychiatry (1996) 0.88
Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dement Geriatr Cogn Disord (2002) 0.87
Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol Psychiatry (1997) 0.85
No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease. Biol Psychiatry (1997) 0.84
The apolipoprotein E epsilon 4 allele is associated with increased behavioral disturbance in Alzheimer's disease. Am J Geriatr Psychiatry (1997) 0.83
Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord (2004) 0.82
Depressive symptoms in Alzheimer disease: assessment and determinants. Alzheimer Dis Assoc Disord (1995) 0.81
Lack of association between the apolipoprotein E genotype and depression in Alzheimer's disease. J Geriatr Psychiatry Neurol (2002) 0.80
Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease. J Geriatr Psychiatry Neurol (2003) 0.80
Gender differences in depression associated with neurologic illness: clinical correlates and pharmacologic response. J Gend Specif Med (2001) 0.80
Apolipoprotein-E and white-matter hyperintensities in late-life depression. Am J Geriatr Psychiatry (2000) 0.80
Major depression in Alzheimer's disease. An interaction between gender and family history. Psychosomatics (1996) 0.79
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA (2003) 6.34
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry (2002) 5.25
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry (2006) 4.29
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med (2005) 3.46
The myth of testing construct validity using factor analysis or correlations with normal or mixed clinical populations: lessons from memory assessment. J Int Neuropsychol Soc (2003) 3.41
Individual and societal wisdom: explaining the paradox of human aging and high well-being. Psychiatry (2014) 3.34
Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry (2004) 3.26
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology (2005) 3.22
Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry (2005) 3.07
Mobile interventions for severe mental illness: design and preliminary data from three approaches. J Nerv Ment Dis (2010) 2.80
Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry (2006) 2.55
Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull (2007) 2.47
Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry (2009) 2.46
The A4 study: stopping AD before symptoms begin? Sci Transl Med (2014) 2.43
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry (2002) 2.39
Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas (2010) 2.30
Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol (2005) 2.30
Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol (2008) 2.25
Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia. J Clin Psychopharmacol (2002) 2.24
Proxy and surrogate consent in geriatric neuropsychiatric research: update and recommendations. Am J Psychiatry (2004) 2.20
Characteristics and admission patterns of patients presenting with syncope to U.S. emergency departments, 1992-2000. Acad Emerg Med (2004) 2.15
Assessing disability in older patients with schizophrenia: results from the WHODAS-II. J Nerv Ment Dis (2004) 2.12
Quantitative evaluation of automated skull-stripping methods applied to contemporary and legacy images: effects of diagnosis, bias correction, and slice location. Hum Brain Mapp (2006) 2.06
Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry (2005) 2.04
Defining and assessing wisdom: a review of the literature. Am J Geriatr Psychiatry (2013) 2.01
Trends in U.S. emergency department visits for mental health conditions, 1992 to 2001. Psychiatr Serv (2005) 2.00
Correlates of self-rated successful aging among community-dwelling older adults. Am J Geriatr Psychiatry (2006) 1.99
Direct assessment of functional abilities: relevance to persons with schizophrenia. Schizophr Res (2004) 1.97
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res (2006) 1.94
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res (2008) 1.91
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2006) 1.90
A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am J Psychiatry (2005) 1.89
A technique for the deidentification of structural brain MR images. Hum Brain Mapp (2007) 1.87
A review of cognitive training in schizophrenia. Schizophr Bull (2003) 1.83
Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement (2008) 1.82
Building blocks of successful aging: a focus group study of older adults' perceived contributors to successful aging. Am J Geriatr Psychiatry (2007) 1.82
A longitudinal study of the use of mental health services by persons with serious mental illness: do Spanish-speaking Latinos differ from English-speaking Latinos and Caucasians? Am J Psychiatry (2007) 1.78
Neuropsychological assessment of dementia. Annu Rev Psychol (2009) 1.76
A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. J Affect Disord (2011) 1.75
Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry (2005) 1.75
Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci (2003) 1.75
Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry (2002) 1.75
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet (2006) 1.73
The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Postgrad Med (2005) 1.73
A review of performance-based measures of functional living skills. J Psychiatr Res (2005) 1.73
Sustained remission of schizophrenia among community-dwelling older outpatients. Am J Psychiatry (2004) 1.72
ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord (2006) 1.70
Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci (2002) 1.69
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol (2008) 1.64
The California Scale of Appreciation: a new instrument to measure the appreciation component of capacity to consent to research. Am J Geriatr Psychiatry (2002) 1.64
Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry (2008) 1.62
Exergames for subsyndromal depression in older adults: a pilot study of a novel intervention. Am J Geriatr Psychiatry (2010) 1.59
Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat (2006) 1.59
Enhancing the informed consent process: a conceptual overview. Behav Sci Law (2006) 1.59
Bipolar disorder in older adults: a critical review. Bipolar Disord (2004) 1.59
Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging (2006) 1.58
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep (2003) 1.58
Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophr Res (2006) 1.58
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol (2007) 1.57
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging (2007) 1.57
Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am J Geriatr Psychiatry (2002) 1.56
Determining when impairment constitutes incapacity for informed consent in schizophrenia research. Br J Psychiatry (2007) 1.56
Identification of Alzheimer disease risk by functional magnetic resonance imaging. Arch Neurol (2005) 1.55
Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol (2003) 1.53
A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. Schizophr Bull (2004) 1.53
Establishing an implementation network: lessons learned from community-based participatory research. Implement Sci (2009) 1.52
What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain (2006) 1.51
Vocational rehabilitation in schizophrenia and other psychotic disorders: a literature review and meta-analysis of randomized controlled trials. J Nerv Ment Dis (2003) 1.51
Association between higher levels of sexual function, activity, and satisfaction and self-rated successful aging in older postmenopausal women. J Am Geriatr Soc (2011) 1.50
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry (2012) 1.48
The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients. Biol Psychiatry (2003) 1.46
Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord (2007) 1.46
Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review. Psychiatr Serv (2009) 1.44
Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res (2004) 1.44
Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry (2004) 1.43
Ethnic disparities in use of public mental health case management services among patients with schizophrenia. Psychiatr Serv (2003) 1.42
Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004. Psychiatr Serv (2007) 1.41
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp (2010) 1.40